Literature DB >> 18424270

Cationic liposomal lipids: from gene carriers to cell signaling.

Caroline Lonez1, Michel Vandenbranden, Jean-Marie Ruysschaert.   

Abstract

Cationic lipids are positively charged amphiphilic molecules which, for most of them, form positively charged liposomes, sometimes in combination with a neutral helper lipid. Such liposomes are mainly used as efficient DNA, RNA or protein carriers for gene therapy or immunization trials. Over the past decade, significant progress has been made in the understanding of the cellular pathways and mechanisms involved in lipoplex-mediated gene transfection but the interaction of cationic lipids with cell components and the consequences of such an interaction on cell physiology remains poorly described. The data reported in the present review provide evidence that cationic lipids are not just carriers for molecular delivery into cells but do modify cellular pathways and stimulate immune or anti-inflammatory responses. Considering the wide number of cationic lipids currently available and the variety of cellular components that could be involved, it is likely that only a few cationic lipid-dependent functions have been identified so far.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424270     DOI: 10.1016/j.plipres.2008.03.002

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  40 in total

1.  Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition.

Authors:  T Chernenko; R R Sawant; M Miljkovic; L Quintero; M Diem; V Torchilin
Journal:  Mol Pharm       Date:  2012-03-15       Impact factor: 4.939

2.  Designer lipids advance systemic siRNA delivery.

Authors:  Yang Liu; Leaf Huang
Journal:  Mol Ther       Date:  2010-04       Impact factor: 11.454

3.  Comparison of transfection efficiency of nonviral gene transfer reagents.

Authors:  Seiichi Yamano; Jisen Dai; Amr M Moursi
Journal:  Mol Biotechnol       Date:  2010-11       Impact factor: 2.695

Review 4.  Multimodality imaging probes: design and challenges.

Authors:  Angelique Louie
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 5.  Drug Carriers: Not an Innocent Delivery Man.

Authors:  Yoon Yeo; Bieong-Kil Kim
Journal:  AAPS J       Date:  2015-05-28       Impact factor: 4.009

Review 6.  Engineering Stem Cells for Biomedical Applications.

Authors:  Perry T Yin; Edward Han; Ki-Bum Lee
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

7.  Improvement of immunogenicity of meningococcal lipooligosaccharide by coformulation with lipidated transferrin-binding protein B in liposomes: implications for vaccine development.

Authors:  Noëlle Mistretta; Bruno Guy; Yves Bérard; François Dalençon; Olivia Fratantonio; Christophe Grégoire; Aurélie Lechevallier; Philippe Lhéritier; Laurent Revet; Monique Moreau; Jean Haensler; Bachra Rokbi
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

Review 8.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

9.  Transcriptional profile in afferent lymph cells following vaccination with liposomes incorporating CpG.

Authors:  Melanie R Neeland; Martin J Elhay; David R Powell; Fernando J Rossello; Els N T Meeusen; Michael J de Veer
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

10.  Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.

Authors:  Xiaomeng Huang; Sebastian Schwind; Bo Yu; Ramasamy Santhanam; Hongyan Wang; Pia Hoellerbauer; Alice Mims; Rebecca Klisovic; Alison R Walker; Kenneth K Chan; William Blum; Danilo Perrotti; John C Byrd; Clara D Bloomfield; Michael A Caligiuri; Robert J Lee; Ramiro Garzon; Natarajan Muthusamy; Ly James Lee; Guido Marcucci
Journal:  Clin Cancer Res       Date:  2013-03-14       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.